» Articles » PMID: 31654406

Significance of the Surgical Hepatic Resection Margin in Patients with a Single Hepatocellular Carcinoma

Overview
Journal Br J Surg
Specialty General Surgery
Date 2019 Oct 27
PMID 31654406
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of a wide surgical margin on the outcome of patients with hepatocellular carcinoma (HCC) has not been evaluated in relation to the type of liver resection performed, anatomical or non-anatomical. The aim of this study was to evaluate the impact of surgical margin status on outcomes in patients undergoing anatomical or non-anatomical resection for solitary HCC.

Methods: Data from patients with solitary HCC who had undergone non-anatomical partial resection (Hr0 group) or anatomical resection of one Couinaud segment (HrS group) between 2000 and 2007 were extracted from a nationwide survey database in Japan. Overall and recurrence-free survival associated with the surgical margin status and width were evaluated in the two groups.

Results: A total of 4457 patients were included in the Hr0 group and 3507 in the HrS group. A microscopically positive surgical margin was associated with poor overall survival in both groups. A negative but 0-mm surgical margin was associated with poorer overall and recurrence-free survival than a wider margin only in the Hr0 group. In the HrS group, the width of the surgical margin was not associated with patient outcome.

Conclusion: Anatomical resection with a negative 0-mm surgical margin may be acceptable. Non-anatomical resection with a negative 0-mm margin was associated with a less favourable survival outcome.

Citing Articles

Surgical treatment for hepatocellular carcinoma in era of multidisciplinary strategies.

Takamoto T, Mihara Y, Nishioka Y, Ichida A, Kawaguchi Y, Akamatsu N Int J Clin Oncol. 2025; 30(3):417-426.

PMID: 39907863 PMC: 11842484. DOI: 10.1007/s10147-025-02703-7.


Liver Resection for Hepatocellular Carcinoma: Recent Advances.

Gundavda K, Patkar S, Varty G, Shah N, Velmurugan K, Goel M J Clin Exp Hepatol. 2024; 15(1):102401.

PMID: 39286759 PMC: 11402310. DOI: 10.1016/j.jceh.2024.102401.


Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.

Xie K, Ma M, Xu F Front Pharmacol. 2024; 15:1336347.

PMID: 38774215 PMC: 11106438. DOI: 10.3389/fphar.2024.1336347.


Long-term outcome of adjuvant radiotherapy upon postoperative relapse of centrally located hepatocellular carcinoma: a real-world study.

Tao C, Hu N, Liu Y, Wang H, Wang Z, Zhang K Sci Rep. 2024; 14(1):8506.

PMID: 38605164 PMC: 11009320. DOI: 10.1038/s41598-024-59180-7.


Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study.

Zheng D, Chen Y, Sun J, Hu Y, Yang P, Zhang Y Clin Transl Radiat Oncol. 2024; 46:100767.

PMID: 38576855 PMC: 10992727. DOI: 10.1016/j.ctro.2024.100767.